Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026 17
Figure 5. Asia Pacific Clinical Nutrition Market, 2019-2026, $ mn 20
Figure 6. Impact of COVID-19 on Business 24
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Clinical Nutrition Market 26
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Clinical Nutrition Market 29
Figure 9. Investment Opportunity Analysis 33
Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Clinical Nutrition Market 36
Figure 11. Breakdown of Asia Pacific Clinical Nutrition Market by Substrate, 2019-2026, % of Revenue 41
Figure 12. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Substrate, Value ($ mn) and Share (%) 41
Figure 13. Asia Pacific Clinical Nutrition Market: Carbohydrates, 2015-2026, $ mn 42
Figure 14. Asia Pacific Clinical Nutrition Market: Lipids, 2015-2026, $ mn 43
Figure 15. Asia Pacific Clinical Nutrition Market: Proteins & Amino Acids, 2015-2026, $ mn 44
Figure 16. Asia Pacific Clinical Nutrition Market: Water & Electrolyte, 2015-2026, $ mn 45
Figure 17. Asia Pacific Clinical Nutrition Market: Dietary Fiber, 2015-2026, $ mn 46
Figure 18. Asia Pacific Clinical Nutrition Market: Antioxidants, 2015-2026, $ mn 47
Figure 19. Asia Pacific Clinical Nutrition Market: Other Substrates, 2015-2026, $ mn 48
Figure 20. Breakdown of Asia Pacific Clinical Nutrition Market by Administration Route, 2019-2026, % of Revenue 49
Figure 21. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Administration Route, Value ($ mn) and Share (%) 50
Figure 22. Asia Pacific Clinical Nutrition Market: Oral or Enteral Administration, 2015-2026, $ mn 51
Figure 23. Asia Pacific Clinical Nutrition Market: Oral Nutrition Supplements, 2015-2026, $ mn 53
Figure 24. Asia Pacific Clinical Nutrition Market: Tube Feeding, 2015-2026, $ mn 54
Figure 25. Asia Pacific Clinical Nutrition Market: Parenteral Administration, 2015-2026, $ mn 55
Figure 26. Asia Pacific Clinical Nutrition Market: Supplemental Parenteral Nutrition, 2015-2026, $ mn 57
Figure 27. Asia Pacific Clinical Nutrition Market: Total Parenteral Nutrition, 2015-2026, $ mn 58
Figure 28. Asia Pacific Clinical Nutrition Market: All-in-One System, 2015-2026, $ mn 59
Figure 29. Asia Pacific Clinical Nutrition Market: Multiple Bottle System, 2015-2026, $ mn 60
Figure 30. Breakdown of Asia Pacific Clinical Nutrition Market by End User, 2019-2026, % of Revenue 61
Figure 31. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by End User, Value ($ mn) and Share (%) 62
Figure 32. Asia Pacific Clinical Nutrition Market: Infant, 2015-2026, $ mn 63
Figure 33. Asia Pacific Clinical Nutrition Market: Children, 2015-2026, $ mn 64
Figure 34. Asia Pacific Clinical Nutrition Market: Adult, 2015-2026, $ mn 65
Figure 35. Asia Pacific Clinical Nutrition Market: Geriatrics, 2015-2026, $ mn 66
Figure 36. Breakdown of Asia Pacific Clinical Nutrition Market by Therapeutic Area, 2019-2026, % of Revenue 68
Figure 37. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Therapeutic Area, Value ($ mn) and Share (%) 68
Figure 38. Asia Pacific Clinical Nutrition Market: Malnutrition, 2015-2026, $ mn 69
Figure 39. Asia Pacific Clinical Nutrition Market: Metabolic Disorders, 2015-2026, $ mn 70
Figure 40. Asia Pacific Clinical Nutrition Market: Gastrointestinal Disorders, 2015-2026, $ mn 71
Figure 41. Asia Pacific Clinical Nutrition Market: Cancer, 2015-2026, $ mn 72
Figure 42. Asia Pacific Clinical Nutrition Market: Neurology, 2015-2026, $ mn 73
Figure 43. Asia Pacific Clinical Nutrition Market: Renal Diseases, 2015-2026, $ mn 74
Figure 44. Asia Pacific Clinical Nutrition Market: Respiratory Diseases, 2015-2026, $ mn 75
Figure 45. Asia Pacific Clinical Nutrition Market: Other Therapeutic Areas, 2015-2026, $ mn 76
Figure 46. Breakdown of Asia Pacific Clinical Nutrition Market by Healthcare Setting, 2019-2026, % of Revenue 78
Figure 47. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Healthcare Setting, Value ($ mn) and Share (%) 78
Figure 48. Asia Pacific Clinical Nutrition Market: Hospitals, 2015-2026, $ mn 79
Figure 49. Asia Pacific Clinical Nutrition Market: Long-term Care Facilities (LTC), 2015-2026, $ mn 80
Figure 50. Asia Pacific Clinical Nutrition Market: Homecare, 2015-2026, $ mn 81
Figure 51. Asia Pacific Clinical Nutrition Market: Inpatient Rehabilitation Facilities, 2015-2026, $ mn 82
Figure 52. Asia Pacific Clinical Nutrition Market: Other Healthcare Settings, 2015-2026, $ mn 83
Figure 53. Breakdown of Asia Pacific Clinical Nutrition Market by Distribution Channel, 2019-2026, % of Revenue 85
Figure 54. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Distribution Channel, Value ($ mn) and Share (%) 85
Figure 55. Asia Pacific Clinical Nutrition Market: Institutional Sales, 2015-2026, $ mn 86
Figure 56. Asia Pacific Clinical Nutrition Market: Supermarkets & Hypermarkets, 2015-2026, $ mn 87
Figure 57. Asia Pacific Clinical Nutrition Market: Pharmacies, 2015-2026, $ mn 88
Figure 58. Asia Pacific Clinical Nutrition Market: Drug Stores, 2015-2026, $ mn 89
Figure 59. Asia Pacific Clinical Nutrition Market: Online Channels, 2015-2026, $ mn 90
Figure 60. Asia Pacific Clinical Nutrition Market: Other Distribution Channels, 2015-2026, $ mn 91
Figure 61. Breakdown of APAC Clinical Nutrition Market by Country, 2019 and 2026, % of Revenue 93
Figure 62. Contribution to APAC 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 94
Figure 63. Clinical Nutrition Market in China, 2015-2026, $ mn 95
Figure 64. Clinical Nutrition Market in Japan, 2015-2026, $ mn 98
Figure 65. Clinical Nutrition Market in India, 2015-2026, $ mn 100
Figure 66. Clinical Nutrition Market in Australia, 2015-2026, $ mn 102
Figure 67. Clinical Nutrition Market in South Korea, 2015-2026, $ mn 104
Figure 68. Clinical Nutrition Market in Rest of APAC, 2015-2026, $ mn 106
Figure 69. Growth Stage of Asia Pacific Clinical Nutrition Industry over the Forecast Period 108
Asia Pacific clinical nutrition market will grow by 8.27% annually with a total addressable market cap of $180.67 billion over 2020-2026 driven by increasing incidence of malnutrition, the rising prevalence of communicable and non-communicable chronic diseases amid COVID-19 pandemic. Highlighted with 35 tables and 69 figures, this 129-page report “Asia Pacific Clinical Nutrition Market 2020-2026 by Substrate, Administration Route (Oral or Enteral, Parenteral), End User, Therapeutic Area, Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific clinical nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific clinical nutrition market in every aspect of the classification from perspectives of Substrate, Administration Route, End User, Therapeutic Area, Healthcare Setting, Distribution Channel, and Country. Based on Substrate, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section. • Carbohydrates • Lipids • Proteins & Amino Acids • Water & Electrolyte • Dietary Fiber • Antioxidants • Other Substrates Based on Administration Route, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section. Oral or Enteral Administration • Oral Nutrition Supplements • Tube Feeding Parenteral Administration • Supplemental Parenteral Nutrition • Total Parenteral Nutrition • All-in-One System • Multiple Bottle System Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section. • Infant • Children • Adult • Geriatrics Based on Therapeutic Area, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section. • Malnutrition • Metabolic Disorders • Gastrointestinal Disorders • Cancer • Neurology • Renal Diseases • Respiratory Diseases • Other Therapeutic Areas Based on Healthcare Setting, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section. • Hospitals • Long-term Care Facilities (LTC) • Homecare • Inpatient Rehabilitation Facilities • Other Healthcare Settings Based on Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section. • Institutional Sales • Supermarkets & Hypermarkets • Pharmacies • Drug Stores • Online Channels • Other Distribution Channels Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) For each country, detailed analysis and data for annual revenue are available for 2019-2026. The breakdown of key national markets by Administration Route, End User, and Therapeutic Area over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in Asia Pacific clinical nutrition market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Abbott Nutrition B Braun Melsungen Ag BASF SE Baxter International Inc. Claris Lifesciences Ltd. Fresenius Kabi Ag Lonza Group AG Nestle Health Science Nutricia Ltd Perrigo Company Plc (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More